Kite Pharma, Inc.
Kite Pharma, Inc. (United States) is linked to 3 FDA-registered manufacturing sites. 7 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Kite Pharma, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/kite-pharma-inc
Overview
Kite Pharma, a Gilead Company, is a biopharmaceutical company that specializes in the development of innovative cancer immunotherapies. Focused on chimeric antigen receptor (CAR) T cell therapies, Kite is committed to advancing breakthrough treatments for patients with hematological cancers.
Therapeutic areas
Registered manufacturing sites (3)
Physical sites registered with the US FDA and resolved to Kite Pharma, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
7 FDA enforcement records linked to this company.
- 4832025-08-27
Written record of investigation incomplete
- 4832025-08-27
Absence of Written Procedures
- 4832025-08-27
Written sanitation procedures lacking
- 4832025-08-27
input/output verification
- 4832021-10-22
Environmental Monitoring System
- 4832019-08-20
Test methods
- 4832019-08-20
SOPs not followed / documented
Is this Kite Pharma, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.